Kangcheng Zheng

Suggest Changes

Writes About:

Learn More
Human glutaminyl cyclase (hQC) appeared as a promising new target with its inhibitors attracted much attention for the treatment of Alzheimer's disease (AD) in recent years. But so far, only a few(More)
  • 1